- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Human Milk Oligosaccharides (HMO) market will register a 31.8% CAGR in terms of revenue, the global market size will reach $ 674.7 million by 2025, from $ 223.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Milk Oligosaccharides (HMO) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Milk Oligosaccharides (HMO) market by type, application, key manufacturers and key regions and countries.
This study considers the Human Milk Oligosaccharides (HMO) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
The segment of 2'-FL & 3-FL holds a comparatively larger share in global market, which accounts for about 70%.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Other
The baby formula holds an important share in terms of applications, and accounts for 70% of the market share.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott
Inbiose
Jennewein Biotechnologie
ZuChem
Elicityl SA
Dextra Laboratories
Glycom
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Milk Oligosaccharides (HMO) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Milk Oligosaccharides (HMO) market by identifying its various subsegments.
Focuses on the key global Human Milk Oligosaccharides (HMO) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Milk Oligosaccharides (HMO) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Milk Oligosaccharides (HMO) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Milk Oligosaccharides (HMO) Consumption 2015-2025
2.1.2 Human Milk Oligosaccharides (HMO) Consumption CAGR by Region
2.2 Human Milk Oligosaccharides (HMO) Segment by Type
2.2.1 2'-FL & 3-FL
2.2.2 Sialyllactose
2.2.3 LNT & LNnT
2.3 Human Milk Oligosaccharides (HMO) Consumption by Type
2.3.1 Global Human Milk Oligosaccharides (HMO) Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Milk Oligosaccharides (HMO) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Milk Oligosaccharides (HMO) Sale Price by Type (2015-2020)
2.4 Human Milk Oligosaccharides (HMO) Segment by Application
2.4.1 Infant Formula
2.4.2 Functional Food & Beverages
2.4.3 Food/Medical Supplements
2.4.4 Other
2.5 Human Milk Oligosaccharides (HMO) Consumption by Application
2.5.1 Global Human Milk Oligosaccharides (HMO) Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Milk Oligosaccharides (HMO) Value and Market Share by Type (2015-2020)
2.5.3 Global Human Milk Oligosaccharides (HMO) Sale Price by Type (2015-2020)
3 Global Human Milk Oligosaccharides (HMO) by Company
3.1 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Company
3.1.1 Global Human Milk Oligosaccharides (HMO) Sales by Company (2018-2020)
3.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Company (2018-2020)
3.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Company
3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Company (2018-2020)
3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Company (2018-2020)
3.3 Global Human Milk Oligosaccharides (HMO) Sale Price by Company
3.4 Global Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Milk Oligosaccharides (HMO) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Milk Oligosaccharides (HMO) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Human Milk Oligosaccharides (HMO) by Regions
4.1 Human Milk Oligosaccharides (HMO) by Regions
4.2 Americas Human Milk Oligosaccharides (HMO) Consumption Growth
4.3 APAC Human Milk Oligosaccharides (HMO) Consumption Growth
4.4 Europe Human Milk Oligosaccharides (HMO) Consumption Growth
4.5 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption Growth
5 Americas
5.1 Americas Human Milk Oligosaccharides (HMO) Consumption by Countries
5.1.1 Americas Human Milk Oligosaccharides (HMO) Consumption by Countries (2015-2020)
5.1.2 Americas Human Milk Oligosaccharides (HMO) Value by Countries (2015-2020)
5.2 Americas Human Milk Oligosaccharides (HMO) Consumption by Type
5.3 Americas Human Milk Oligosaccharides (HMO) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Milk Oligosaccharides (HMO) Consumption by Regions
6.1.1 APAC Human Milk Oligosaccharides (HMO) Consumption by Regions (2015-2020)
6.1.2 APAC Human Milk Oligosaccharides (HMO) Value by Regions (2015-2020)
6.2 APAC Human Milk Oligosaccharides (HMO) Consumption by Type
6.3 APAC Human Milk Oligosaccharides (HMO) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Human Milk Oligosaccharides (HMO) by Countries
7.1.1 Europe Human Milk Oligosaccharides (HMO) Consumption by Countries (2015-2020)
7.1.2 Europe Human Milk Oligosaccharides (HMO) Value by Countries (2015-2020)
7.2 Europe Human Milk Oligosaccharides (HMO) Consumption by Type
7.3 Europe Human Milk Oligosaccharides (HMO) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Human Milk Oligosaccharides (HMO) by Countries
8.1.1 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Value by Countries (2015-2020)
8.2 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption by Type
8.3 Middle East & Africa Human Milk Oligosaccharides (HMO) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Milk Oligosaccharides (HMO) Distributors
10.3 Human Milk Oligosaccharides (HMO) Customer
11 Global Human Milk Oligosaccharides (HMO) Market Forecast
11.1 Global Human Milk Oligosaccharides (HMO) Consumption Forecast (2021-2025)
11.2 Global Human Milk Oligosaccharides (HMO) Forecast by Regions
11.2.1 Global Human Milk Oligosaccharides (HMO) Forecast by Regions (2021-2025)
11.2.2 Global Human Milk Oligosaccharides (HMO) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Milk Oligosaccharides (HMO) Forecast by Type
11.8 Global Human Milk Oligosaccharides (HMO) Forecast by Application
12 Key Players Analysis
12.1 Abbott
12.1.1 Company Information
12.1.2 Human Milk Oligosaccharides (HMO) Product Offered
12.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Abbott Latest Developments
12.2 Inbiose
12.2.1 Company Information
12.2.2 Human Milk Oligosaccharides (HMO) Product Offered
12.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Inbiose Latest Developments
12.3 Jennewein Biotechnologie
12.3.1 Company Information
12.3.2 Human Milk Oligosaccharides (HMO) Product Offered
12.3.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Jennewein Biotechnologie Latest Developments
12.4 ZuChem
12.4.1 Company Information
12.4.2 Human Milk Oligosaccharides (HMO) Product Offered
12.4.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 ZuChem Latest Developments
12.5 Elicityl SA
12.5.1 Company Information
12.5.2 Human Milk Oligosaccharides (HMO) Product Offered
12.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Elicityl SA Latest Developments
12.6 Dextra Laboratories
12.6.1 Company Information
12.6.2 Human Milk Oligosaccharides (HMO) Product Offered
12.6.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Dextra Laboratories Latest Developments
12.7 Glycom
12.7.1 Company Information
12.7.2 Human Milk Oligosaccharides (HMO) Product Offered
12.7.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Glycom Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Milk Oligosaccharides (HMO) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
